vs
AWARE INC（AWRE）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
Profound Medical Corp.的季度营收约是AWARE INC的1.8倍（$6.0M vs $3.4M）
AWARE Inc.是一家专注于生物识别软件与身份核验解决方案的科技企业，开发指纹、面部、虹膜识别等相关产品，主要服务政府机构、金融机构及企业客户，市场覆盖北美及全球受监管领域。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
AWRE vs PROF — 直观对比
营收规模更大
PROF
是对方的1.8倍
$3.4M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.4M | $6.0M |
| 净利润 | — | $-8.2M |
| 毛利率 | 90.1% | 66.8% |
| 营业利润率 | -107.8% | -123.3% |
| 净利率 | — | -136.8% |
| 营收同比 | -6.2% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AWREPROF
| Q1 26 | $3.4M | — | ||
| Q4 25 | $4.7M | $6.0M | ||
| Q3 25 | $5.1M | $5.1M | ||
| Q2 25 | $3.9M | $2.0M | ||
| Q1 25 | $3.6M | $2.3M | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $3.8M | — | ||
| Q2 24 | $4.3M | — |
净利润AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | $-1.5M | $-8.2M | ||
| Q3 25 | $-1.1M | $-8.0M | ||
| Q2 25 | $-1.8M | $-15.7M | ||
| Q1 25 | $-1.6M | $-10.7M | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-1.2M | — | ||
| Q2 24 | $-1.1M | — |
毛利率AWREPROF
| Q1 26 | 90.1% | — | ||
| Q4 25 | 94.7% | 66.8% | ||
| Q3 25 | 90.4% | 77.7% | ||
| Q2 25 | 91.3% | 81.7% | ||
| Q1 25 | 93.2% | 79.2% | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 93.0% | — | ||
| Q2 24 | 93.8% | — |
营业利润率AWREPROF
| Q1 26 | -107.8% | — | ||
| Q4 25 | -31.1% | -123.3% | ||
| Q3 25 | -25.2% | -176.2% | ||
| Q2 25 | -50.3% | -696.9% | ||
| Q1 25 | -51.3% | -477.0% | ||
| Q4 24 | -30.7% | — | ||
| Q3 24 | -38.1% | — | ||
| Q2 24 | -31.0% | — |
净利率AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | -31.2% | -136.8% | ||
| Q3 25 | -20.5% | -157.7% | ||
| Q2 25 | -45.4% | -792.3% | ||
| Q1 25 | -44.3% | -458.1% | ||
| Q4 24 | -24.8% | — | ||
| Q3 24 | -30.3% | — | ||
| Q2 24 | -25.2% | — |
每股收益（稀释后）AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | $-0.07 | $0.27 | ||
| Q3 25 | $-0.05 | $0.26 | ||
| Q2 25 | $-0.08 | $0.52 | ||
| Q1 25 | $-0.08 | $0.36 | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $-0.06 | — | ||
| Q2 24 | $-0.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.6M | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | — | $66.4M |
| 总资产 | $33.2M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资AWREPROF
| Q1 26 | $4.6M | — | ||
| Q4 25 | $7.3M | $59.7M | ||
| Q3 25 | $6.3M | $24.8M | ||
| Q2 25 | $7.3M | $35.2M | ||
| Q1 25 | $8.5M | $46.4M | ||
| Q4 24 | $13.0M | — | ||
| Q3 24 | $11.2M | — | ||
| Q2 24 | $11.5M | — |
总债务AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | $26.1M | $66.4M | ||
| Q3 25 | $27.2M | $32.1M | ||
| Q2 25 | $28.1M | $39.3M | ||
| Q1 25 | $29.5M | $50.8M | ||
| Q4 24 | $30.9M | — | ||
| Q3 24 | $31.9M | — | ||
| Q2 24 | $32.6M | — |
总资产AWREPROF
| Q1 26 | $33.2M | — | ||
| Q4 25 | $37.2M | $77.5M | ||
| Q3 25 | $40.3M | $42.3M | ||
| Q2 25 | $38.1M | $49.7M | ||
| Q1 25 | $39.9M | $60.9M | ||
| Q4 24 | $42.6M | — | ||
| Q3 24 | $43.7M | — | ||
| Q2 24 | $43.2M | — |
负债/权益比AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | $1.0M | $-6.6M | ||
| Q3 25 | $-2.4M | $-9.6M | ||
| Q2 25 | $-1.2M | $-13.7M | ||
| Q1 25 | $-2.9M | $-8.3M | ||
| Q4 24 | $683.0K | — | ||
| Q3 24 | $-765.0K | — | ||
| Q2 24 | $-668.0K | — |
自由现金流AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | $926.0K | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-3.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | 19.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -82.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度AWREPROF
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
